Finally, inhibition of mSWI/SNF ATP-dependent chromatin remodeling activity using three different SMARCA4/2-specific orally bioavailable small-molecule inhibitors and degraders attenuates ACE2 expression and reduces infection of numerous SARS-CoV-2 variants. Here, SMARCA4 is linked to infection.